Arm in Arm With Crohn’s Disease Experts: A Master Class in Noninvasive Imaging and Histologic Endpoints

Webinar/Online

Thursday, September 25, 2025 at 6:30pm CT - 7:30pm CT
Add this event to your calendar

Info

Topic

Gastroenterologists and gastroenterology nurse practitioners and physician associates who manage patients with Crohn’s disease (CD) will learn about treat-to-target strategies, noninvasive imaging, and the newest treatment targets to improve patient care.

Credits Offered

This event offers 1.0 contact hour to attendees.
Accreditation Info: AANC.

Additional Information

Goal Statement
The goal of this activity is to improve knowledge, competence, and performance among GI HCP learners on treat-to-target strategies in CD, noninvasive imaging, and the newest treatment targets, including histological endpoints, to optimize and individualize patient care.

Target Audience
The target audience for this education is gastroenterologists, gastroenterology nurse practitioners and physician associates who manage patients with CD.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate treatment response and treatment advancement needs within a treat-to-target framework for patients with moderate to severe CD

  • Integrate noninvasive imaging-based assessments of mucosal and transmural inflammation into treatment response monitoring for patients with CD

  • Utilize histological analysis in management decisions for patients with CD

Agenda:

  • Welcome & Introduction
  • Treat to Target in CD: Where Are We Now?
  • Noninvasive Imaging Tools to Assess Mucosal and Transmural Inflammation
  • Evolving Role of Histology in CD Management
  • Summary of Clinical Takeaways
  • Final Q&A

Speakers

Jordan Axelrad
Jordan Axelrad MD, MPH, FACG

Assistant Professor
Gastroenterology
NYU Grossman School of Medicine
New York, United States of America

Interested in attending this event?

Enter your email address below to register for this event.
If you do not have an account, create your account.